Selected-GenAtlas references SOURCE GeneCards NCBI Gene Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SELENOI contributors: mct/ - updated : 17-11-2021
HGNC name ethanolaminephosphotransferase 1 (CDP-ethanolamine-specific)
HGNC id 29361
DNA
TYPE functioning gene
STRUCTURE 49.81 kb     10 Exon(s)
MAPPING cloned Y linked N status provisional
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
10 - 8066 45 397 - 2007
EXPRESSION
Type ubiquitous
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Nervousbrainhindbraincerebellum highly
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Nervousperipherous   
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • CDP-alcohol phosphatidyltransferase signature
  • a common motif conserved in phospholipid synthases
  • HOMOLOGY
    Homologene
    FAMILY
  • selenoproteins family
  • CDP-alcohol phosphatidyltransferase class-I family
  • CATEGORY enzyme
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm,organelle,membrane
    intracellular,cytoplasm,organelle,endoplasmic reticulum
    intracellular,cytoplasm,organelle,Golgi
    text integral membrane protein
    basic FUNCTION
  • involved in the biosynthesis of phosphatidylethanolamine via the Kennedy pathway
  • indispensable role of SELENOI in the myelination process and neurodevelopment, and in the maintenance of normal homeostasis of ether-linked phospholipids
  • enzyme participating in two metabolic pathways for the synthesis of phosphatidylethanolamine (PE) and plasmenyl PE
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • upregulated ethanolamine phospholipid synthesis via SELENOI is required for effective metabolic reprogramming during T cell activation
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) SPG81
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional       loss of function
    lowers but does not completely diminish de novo synthesis of phosphatidylethanolamine (PE) and plasmenyl PE during T cell activation
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS